• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic

Doctors issue call to action to eliminate barriers to automated insulin delivery

April 9, 2025 By Sean Whooley

Diabetes automated insulin delivery AID platforms Insulet Medtronic Tandem Sequel Beta Bionics

Key opinion leaders issued a call to action to the diabetes community to recognize the importance of automated insulin delivery (AID). A number of doctors issued this call, published by Mary Ann Liebert’s Diabetes Technology & Therapeutics, to implement the advances made in the AID technology space. They say pivotal trials and real-world data support […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Beta Bionics, Diabetes, Insulet, Medtronic, Sequel Med Tech, Tandem Diabetes Care

Medtronic has a new leader in its Diabetes unit

April 7, 2025 By Sean Whooley

Laura Endres Medtronic Diabetes LinkedIn

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit. On LinkedIn, Laura Endres said in a post that last week was her first with the medtech giant’s Diabetes unit. She spent more than a decade at continuous glucose monitor (CGM) maker Dexcom, bringing significant diabetes […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Personnel, Technology Tagged With: Medtronic, Personnel Moves

The biggest diabetes tech news out of ATTD 2025

March 24, 2025 By Sean Whooley

Tandem Diabetes Care child wearing mobi pump control IQ+

Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, ATTD 2025, CamDiab, Dexcom, Insulet, Medtronic, modularmedical, Sequel Med Tech, Tandem Diabetes Care, Ypsomed

Medtronic reports first real-world data on smart insulin pen system

March 20, 2025 By Sean Whooley

Medtronic Simplera CGM InPen Smart MDI system (1)

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic’s Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor (CGM). Data showed how the system, designed for people with diabetes using multiple daily injections (MDI) when used as intended, […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ATTD 2025, Medtronic

Data supports Medtronic Prevail paclitaxel-coated balloon

March 10, 2025 By Sean Whooley

Medtronic Prevail drug-coated balloon

Medtronic (NYSE: MDT) announced results from a registry highlighting the effectiveness of the Prevail drug-coated balloon (DCB). Dr. Sacharias von Koch of the dept. of cardiology and clinical sciences at Lund University, Skåne University Hospital in Sweden presented findings from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) at Cardiovascular Research Technologies (CRT) 2025 in […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Device Combinations, Vascular Tagged With: Medtronic

Medtronic enrolls first patient in drug-coated balloon study

February 26, 2025 By Sean Whooley

Medtronic logo updated

Medtronic (NYSE: MDT) announced today that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB). The study evaluates the paclitaxel-coated balloon catheter for in-stent restenosis (ISR) and de novo small vessel disease. Dr. Ziad Ali, director of the DeMatteis Cardiovascular Institute at St Francis Hospital & Heart Center (New […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Device Combinations Tagged With: Medtronic

Data outlines need for CGM study design guidelines

February 21, 2025 By Sean Whooley

Medtronic Simplera Abbott FreeStyle Libre 3 Dexcom G7

A study looking at three leading continuous glucose monitors (CGMs), including systems from Abbott and Dexcom, signaled the need for new guidelines, investigators say. Published in the Journal of Diabetes Science and Technology, the study evaluated the latest-generation Abbott FreeStyle Libre 3, Dexcom G7 and Medtronic Simplera CGMs against different comparator methods and during clinically […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Dexcom, Medtronic

Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA

February 18, 2025 By Sean Whooley

Medtronic MiniMed 780G automated insulin delivery system with Simplera Sync CGM Sensor

Third-quarter results for Medtronic (NYSE:MDT) today included a timeline for a planned label expansion for its automated insulin delivery platform. The medtech giant posted an overall revenue miss for the three months, despite growth in the Diabetes business. (Read more about the company’s third-quarter results at sibling site MassDevice.) Speaking on the company’s earnings call […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), MassDevice Earnings Roundup, Patient Monitoring, Regulatory/Compliance, Technology, Wall Street Beat Tagged With: Medtronic

Medtronic warns on air pressure issue with certain MiniMed insulin pumps in Europe

February 14, 2025 By Sean Whooley

MiniMed 780G with Guardian 4 Medtronic

Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe related to multiple versions of its MiniMed insulin pump systems. The medtech giant’s notice includes models of the MiniMed 640G, 670G, 720G, 740G, 770G and 780G insulin pumps. During quality testing performed by Medtronic, the company said it recently found that changes in air pressure […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Recalls, Regulatory/Compliance, Technology Tagged With: Medtronic

Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business

January 17, 2025 By Sean Whooley

Medtronic MiniMed 780G automated insulin delivery system with Simplera Sync CGM Sensor

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say. Speaking at the JP Morgan Healthcare conference this week, CEO Geoff Martha highlighted the potential opportunity in diabetes. “You’ve seen us turn around this business over the last couple of years,” Martha said. “It’s grown above our […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Medtronic

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS